VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe

CONCLUSIONS: The VACCELERATE Site Network enables a constantly updated Europe-wide mapping of experienced clinical sites interested in executing vaccine trials. The network is already in use as a rapid-turnaround single contact point for the identification of vaccine trials sites in Europe.PMID:37210309 | PMC:PMC10194816 | DOI:10.1016/j.vaccine.2023.05.006
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research